ArticleRheumatology international2025

Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework.

Vienna Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.